Understanding the role of COL1A1 in diseases has led to therapeutic strategies aimed at modulating its expression. For instance, antifibrotic drugs aim to reduce the excessive production of COL1A1 in fibrotic conditions, thereby ameliorating the disease symptoms and progression.
